• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于罗丹明B的荧光探针的构效关系研究及其被抗癌铂(II)化合物激活的情况

Structure-activity relationship studies on rhodamine B-based fluorogenic probes and their activation by anticancer platinum(II) compounds.

作者信息

Ong Jun Xiang, Yap Jian Yu, Yap Siew Qi, Ang Wee Han

机构信息

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543, Singapore.

Department of Chemistry, National University of Singapore, 3 Science Drive 3, Singapore 117543, Singapore; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, 28 Medical Drive, Singapore 117456, Singapore.

出版信息

J Inorg Biochem. 2015 Dec;153:272-278. doi: 10.1016/j.jinorgbio.2015.10.002. Epub 2015 Oct 22.

DOI:10.1016/j.jinorgbio.2015.10.002
PMID:26518138
Abstract

Fluorescence microscopy has emerged as an attractive technique for imaging intracellular Pt species arising from exposure to clinical anticancer drugs such as cisplatin. A rhodamine-B based fluorogenic probe termed Rho-DDTC can be activated selectively in the presence of Pt(II) compounds, and possesses the ability to discriminate Pt(II) species from Pt(IV) carboxylate prodrug complexes, thereby providing a unique platform to investigate the reduction of these Pt(IV) complexes after cell entry. In this report, we seek to establish the mechanism of activation of Rho-DDTC through a structure-activity relationship study on its structural analogues.

摘要

荧光显微镜已成为一种颇具吸引力的技术,可用于对细胞内由接触顺铂等临床抗癌药物产生的铂物种进行成像。一种名为Rho-DDTC的基于罗丹明B的荧光探针可在铂(II)化合物存在下被选择性激活,并具有区分铂(II)物种与铂(IV)羧酸盐前药复合物的能力,从而为研究这些铂(IV)复合物进入细胞后的还原过程提供了一个独特的平台。在本报告中,我们试图通过对其结构类似物的构效关系研究来确定Rho-DDTC的激活机制。

相似文献

1
Structure-activity relationship studies on rhodamine B-based fluorogenic probes and their activation by anticancer platinum(II) compounds.基于罗丹明B的荧光探针的构效关系研究及其被抗癌铂(II)化合物激活的情况
J Inorg Biochem. 2015 Dec;153:272-278. doi: 10.1016/j.jinorgbio.2015.10.002. Epub 2015 Oct 22.
2
Fluorogenic platinum(IV) complexes as potential predictors for the design of hypoxia-activated platinum(IV) prodrugs.荧光铂(IV)配合物作为设计缺氧激活型铂(IV)前药的潜在预测物。
Dalton Trans. 2024 Sep 10;53(35):14811-14816. doi: 10.1039/d4dt02173h.
3
Development of a Pre-assembled Through-Bond Energy Transfer (TBET) Fluorescent Probe for Ratiometric Sensing of Anticancer Platinum(ll) Complexes.开发一种预组装的键上能量转移(TBET)荧光探针,用于比率型检测抗癌铂(II)配合物。
Chem Asian J. 2020 May 4;15(9):1449-1455. doi: 10.1002/asia.202000157. Epub 2020 Mar 30.
4
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs.功能性荧光无孔二氧化硅纳米颗粒作为铂(IV)抗癌前药的载体
J Inorg Biochem. 2015 Oct;151:132-42. doi: 10.1016/j.jinorgbio.2015.08.001. Epub 2015 Aug 6.
5
Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles.近红外光介导的顺铂前药光激活及上转换发光纳米粒子的细胞凋亡成像
Angew Chem Int Ed Engl. 2014 Jan 20;53(4):1012-6. doi: 10.1002/anie.201308834. Epub 2013 Dec 6.
6
Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies.3,6-二氧杂-1,8-辛二硫醇被铂(IV)抗癌前药和模型配合物氧化:动力学和机理研究。
J Phys Chem B. 2012 Jun 7;116(22):6522-8. doi: 10.1021/jp302600a. Epub 2012 May 22.
7
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug.用于靶向顺铂类 Pt(IV)抗癌前药的杂化无机(无孔二氧化硅)/有机(海藻酸盐)核壳平台。
J Inorg Biochem. 2018 Dec;189:185-191. doi: 10.1016/j.jinorgbio.2018.09.019. Epub 2018 Oct 2.
8
A Ratiometric Fluorescent Probe for Cisplatin: Investigating the Intracellular Reduction of Platinum(IV) Prodrug Complexes.一种用于顺铂的比率荧光探针:研究铂(IV)前药复合物的细胞内还原。
Angew Chem Int Ed Engl. 2019 Jan 2;58(1):164-167. doi: 10.1002/anie.201810361. Epub 2018 Dec 4.
9
BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity.BODI-Pt,一种基于卡铂的可绿光激活的铂(IV)抗癌前药,具有增强的激活和细胞毒性。
Inorg Chem. 2020 Aug 17;59(16):11823-11833. doi: 10.1021/acs.inorgchem.0c01880. Epub 2020 Aug 6.
10
Oxidation of anticancer Pt(II) complexes with monodentate phosphane ligands: towards stable but active Pt(IV) prodrugs.单核膦配体抗癌 Pt(II) 配合物的氧化:稳定但活性的 Pt(IV) 前药的研究。
Chem Commun (Camb). 2013 May 25;49(42):4806-8. doi: 10.1039/c3cc38416k.

引用本文的文献

1
Recent Advances on Pt-Based Compounds for Theranostic Applications.基于 Pt 的化合物在治疗诊断应用方面的最新进展。
Molecules. 2024 Jul 23;29(15):3453. doi: 10.3390/molecules29153453.
2
New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers.顺铂联合供电子化合物的新联合化疗治疗多种癌症。
Sci Rep. 2021 Jan 12;11(1):788. doi: 10.1038/s41598-020-80876-z.